Kaoru Mitsui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kaoru Mitsui has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
Akihiko Yoshimura
Institute of Life Science, Kurume University, 2432-3 Aikawa-machi, Kurume, Fukuoka, 839-0861, Japan
5 shared publications- Ken-Ichiro Kosai
Department of Gene Therapy and Regenerative Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8544, Japan
5 shared publications - Motoaki Ohtsubo
Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
5 shared publications Akira Matsumoto
3 shared publicationsSatoshi Ohtsuka
Institute of Life Science, Kurume University, 2432-3 Aikawa-machi, Kurume, Fukuoka, 839-0861, Japan
3 shared publicationsShyu Tanimura
Institute of Life Sciences, Kurume University, Japan
3 shared publications
Latest Publications
- Open Access
- 24 October 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 737, 150894
Triple-regulated conditionally replicating adenovirus for effective and safer treatment of peritoneal carcinomatosis
- 24 October 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 737, 150894
Open AccessTriple-regulated conditionally replicating adenovirus for effective and safer treatment of peritoneal carcinomatosis
- 1 February 2021
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 541, 78-83
Optimization of adenoviral gene transfer in human pluripotent stem cells
- 1 February 2021
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 541, 78-83
Optimization of adenoviral gene transfer in human pluripotent stem cells
- Open Access
- 1 June 2017
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 5, 51-58
Viral Vector-Based Innovative Approaches to Directly Abolishing Tumorigenic Pluripotent Stem Cells for Safer Regenerative Medicine
- 1 June 2017
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 5, 51-58
Open AccessViral Vector-Based Innovative Approaches to Directly Abolishing Tumorigenic Pluripotent Stem Cells for Safer Regenerative Medicine
- Open Access
- 1 January 2015
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 2, 15026
Conditionally replicating adenovirus prevents pluripotent stem cell–derived teratoma by specifically eliminating undifferentiated cells
- 1 January 2015
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 2, 15026
Open AccessConditionally replicating adenovirus prevents pluripotent stem cell–derived teratoma by specifically eliminating undifferentiated cells
- Open Access
- 27 January 2014
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 12 (1) , 27
Survivin-responsive conditionally replicating adenovirus kills rhabdomyosarcoma stem cells more efficiently than their progeny
Effective methods for eradicating cancer stem cells (CSCs), which are highly tumorigenic and resistant to conventional therapies, are urgently needed. Our previous studies demonstrated that survivin-responsive conditionally replicating adenoviruses regulated with multiple factors (Surv.m-CRAs), which selectively replicate in and kill a broad range of cancer-cell types, are promising anticancer agents. Here we examined the therapeutic potentials of a Surv.m-CRA against rhabdomyosarcoma stem cells (RSCs), in order to assess its clinical effectiveness and usefulness.
- 27 January 2014
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 12 (1) , 27
Open AccessSurvivin-responsive conditionally replicating adenovirus kills rhabdomyosarcoma stem cells more efficiently than their progeny
Effective methods for eradicating cancer stem cells (CSCs), which are highly tumorigenic and resistant to conventional therapies, are urgently needed. Our previous studies demonstrated that survivin-responsive conditionally replicating adenoviruses regulated with multiple factors (Surv.m-CRAs), which selectively replicate in and kill a broad range of cancer-cell types, are promising anticancer agents. Here we examined the therapeutic potentials of a Surv.m-CRA against rhabdomyosarcoma stem cells (RSCs), in order to assess its clinical effectiveness and usefulness.
- 1 October 2009
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 388 (4) , 711-717
Gene targeting in human pluripotent stem cells with adeno-associated virus vectors
- 1 October 2009
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 388 (4) , 711-717
Gene targeting in human pluripotent stem cells with adeno-associated virus vectors
- 1 September 2009
- Published by SAGE Publications in Zebrafish
- Vol. 6 (3) , 253-258
Introduction of a Foreign Gene into Zebrafish and Medaka Cells Using Adenoviral Vectors
Viral vectors represent a tractable system that can efficiently introduce an exogenous gene into different target cells and are thus a potentially powerful genetic manipulation tool. In our current study, we investigated the infection efficiency of mammalian virus vectors, adenoviruses (Ads), adeno-associated viruses, and lentiviruses to the Sertoli cell line and the newly established cell line from a single embryo in zebrafish. Among the viral vectors tested, Ads showed the highest infection efficiency of 107–108 green fluorescent protein–transducing units (gtu)/mL in zebrafish cells. In addition, the adenoviral vector was also infected at 105 gtu/mL in the medaka testicular somatic cell line that was established from the testes of p53-deficient mutant. Further, we found that Ads could successfully infect cultured male zebrafish germ cells. Our results thus indicate that the adenoviral vector could be used as a chromosomally nonintegrating vector system in zebrafish.
- 1 September 2009
- Published by SAGE Publications in Zebrafish
- Vol. 6 (3) , 253-258
Introduction of a Foreign Gene into Zebrafish and Medaka Cells Using Adenoviral Vectors
Viral vectors represent a tractable system that can efficiently introduce an exogenous gene into different target cells and are thus a potentially powerful genetic manipulation tool. In our current study, we investigated the infection efficiency of mammalian virus vectors, adenoviruses (Ads), adeno-associated viruses, and lentiviruses to the Sertoli cell line and the newly established cell line from a single embryo in zebrafish. Among the viral vectors tested, Ads showed the highest infection efficiency of 107–108 green fluorescent protein–transducing units (gtu)/mL in zebrafish cells. In addition, the adenoviral vector was also infected at 105 gtu/mL in the medaka testicular somatic cell line that was established from the testes of p53-deficient mutant. Further, we found that Ads could successfully infect cultured male zebrafish germ cells. Our results thus indicate that the adenoviral vector could be used as a chromosomally nonintegrating vector system in zebrafish.
- 16 September 2008
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (37) , 13781-13786
Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors
Human embryonic stem (hES) cells are regarded as a potentially unlimited source of cellular materials for regenerative medicine. For biological studies and clinical applications using primate ES cells, the development of a general strategy to obtain efficient gene delivery and genetic manipulation, especially gene targeting via homologous recombination (HR), would be of paramount importance. However, unlike mouse ES (mES) cells, efficient strategies for transient gene delivery and HR in hES cells have not been established. Here, we report that helper-dependent adenoviral vectors (HDAdVs) were able to transfer genes in hES and cynomolgus monkey ( Macaca fasicularis ) ES (cES) cells efficiently. Without losing the undifferentiated state of the ES cells, transient gene transfer efficiency was ≈100%. Using HDAdVs with homology arms, approximately one out of 10 chromosomal integrations of the vector was via HR, whereas the rate was only ≈1% with other gene delivery methods. Furthermore, in combination with negative selection, ≈45% of chromosomal integrations of the vector were targeted integrations, indicating that HDAdVs would be a powerful tool for genetic manipulation in hES cells and potentially in other types of human stem cells, such as induced pluripotent stem (iPS) cells.
- 16 September 2008
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (37) , 13781-13786
Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors
Human embryonic stem (hES) cells are regarded as a potentially unlimited source of cellular materials for regenerative medicine. For biological studies and clinical applications using primate ES cells, the development of a general strategy to obtain efficient gene delivery and genetic manipulation, especially gene targeting via homologous recombination (HR), would be of paramount importance. However, unlike mouse ES (mES) cells, efficient strategies for transient gene delivery and HR in hES cells have not been established. Here, we report that helper-dependent adenoviral vectors (HDAdVs) were able to transfer genes in hES and cynomolgus monkey ( Macaca fasicularis ) ES (cES) cells efficiently. Without losing the undifferentiated state of the ES cells, transient gene transfer efficiency was ≈100%. Using HDAdVs with homology arms, approximately one out of 10 chromosomal integrations of the vector was via HR, whereas the rate was only ≈1% with other gene delivery methods. Furthermore, in combination with negative selection, ≈45% of chromosomal integrations of the vector were targeted integrations, indicating that HDAdVs would be a powerful tool for genetic manipulation in hES cells and potentially in other types of human stem cells, such as induced pluripotent stem (iPS) cells.
- 12 May 2006
- Published by Wiley in Journal of Phycology
- Vol. 42 (3) , 679-695
PHYLOGENETIC RELATIONSHIPS AND TAXONOMY OF SARCINOID GREEN ALGAE: CHLOROSARCINOPSIS, DESMOTETRA, SARCINOCHLAMYS GEN. NOV., NEOCHLOROSARCINA, AND CHLOROSPHAEROPSIS (CHLOROPHYCEAE, CHLOROPHYTA)1
We investigated the phylogenetic relationships and the taxonomy of 20 sarcinoid strains by their morphological features and using 18S rDNA sequence data. Nineteen strains of Chlorosarcinopsis (Gerneck) Herndon and allied genera were divided into four groups (A–D). Group A, comprising eight species, was concordant with the description of Chlorosarcinopsis and divided into four polyphyletic subgroups. Group B included two species of Chlorosarcinopsis and two strains of Desmotetra stigmatica (Deason) Deason et Floyd, all of which had parallel thylakoid membranes in pyrenoid matrices, and zoospores bearing apical stigma and subapical flagellar apparatus. The definition of Desmotetra Deason et Floyd was emended to include these features, and Chlorosarcinopsis delicata S. Watanabe was transferred to this genus. Group C comprised Chlorosarcina stigmatica Deason (ASIB.T105), for which we proposed Sarcinochlamys gen. nov., a genus distinct from Chlorosarcina Gerneck in having walled zoospores. Group D, comprising six species, corresponded to Neochlorosarcina and was divided into two subgroups. The presence of thin cell walls in Neochlorosarcina S. Watanabe was ascertained as a valid feature for circumscribing the sarcinoid genera. The physiological experiments on the species of Chlorosarcinopsis and Chlorosarcina by Groover and Bold (1968) were assessed based on the phylogenetic results. Groups (A, B, D) were roughly characterized by these features: algal mass color, utilization of selected nitrogen compounds and carbon sources under light/dark and aerobic/anaerobic conditions, and requirement for vitamin B12. Molecular analysis revealed that Chlorosphaeropsis alveolata Herndon had closer affinity with solitary Protosiphon Klebs and Spongiochloris Starr than with sarcinoid members.
- 12 May 2006
- Published by Wiley in Journal of Phycology
- Vol. 42 (3) , 679-695
PHYLOGENETIC RELATIONSHIPS AND TAXONOMY OF SARCINOID GREEN ALGAE: CHLOROSARCINOPSIS, DESMOTETRA, SARCINOCHLAMYS GEN. NOV., NEOCHLOROSARCINA, AND CHLOROSPHAEROPSIS (CHLOROPHYCEAE, CHLOROPHYTA)1
We investigated the phylogenetic relationships and the taxonomy of 20 sarcinoid strains by their morphological features and using 18S rDNA sequence data. Nineteen strains of Chlorosarcinopsis (Gerneck) Herndon and allied genera were divided into four groups (A–D). Group A, comprising eight species, was concordant with the description of Chlorosarcinopsis and divided into four polyphyletic subgroups. Group B included two species of Chlorosarcinopsis and two strains of Desmotetra stigmatica (Deason) Deason et Floyd, all of which had parallel thylakoid membranes in pyrenoid matrices, and zoospores bearing apical stigma and subapical flagellar apparatus. The definition of Desmotetra Deason et Floyd was emended to include these features, and Chlorosarcinopsis delicata S. Watanabe was transferred to this genus. Group C comprised Chlorosarcina stigmatica Deason (ASIB.T105), for which we proposed Sarcinochlamys gen. nov., a genus distinct from Chlorosarcina Gerneck in having walled zoospores. Group D, comprising six species, corresponded to Neochlorosarcina and was divided into two subgroups. The presence of thin cell walls in Neochlorosarcina S. Watanabe was ascertained as a valid feature for circumscribing the sarcinoid genera. The physiological experiments on the species of Chlorosarcinopsis and Chlorosarcina by Groover and Bold (1968) were assessed based on the phylogenetic results. Groups (A, B, D) were roughly characterized by these features: algal mass color, utilization of selected nitrogen compounds and carbon sources under light/dark and aerobic/anaerobic conditions, and requirement for vitamin B12. Molecular analysis revealed that Chlorosphaeropsis alveolata Herndon had closer affinity with solitary Protosiphon Klebs and Spongiochloris Starr than with sarcinoid members.
- Open Access
- 29 May 2003
- Published by Springer Nature in Nature
- Vol. 423 (6939) , 541-545
Role of ERas in promoting tumour-like properties in mouse embryonic stem cells
Embryonic stem (ES) cells are pluripotent cells derived from early mammalian embryos1,2. Their immortality and rapid growth make them attractive sources for stem cell therapies3; however, they produce tumours (teratomas) when transplanted, which could preclude their therapeutic usage4. Why ES cells, which lack chromosomal abnormalities, possess tumour-like properties is largely unknown. Here we show that mouse ES cells specifically express a Ras-like gene, which we have named ERas. We show that human HRasp, which is a recognized pseudogene, does not contain reported base substitutions and instead encodes the human orthologue of ERas. This protein contains amino-acid residues identical to those present in active mutants of Ras5 and causes oncogenic transformation in NIH 3T3 cells. ERas interacts with phosphatidylinositol-3-OH kinase6 but not with Raf7,8. ERas-null ES cells maintain pluripotency but show significantly reduced growth and tumorigenicity, which are rescued by expression of ERas complementary DNA or by activated phosphatidylinositol-3-OH kinase. We conclude that the transforming oncogene ERas is important in the tumour-like growth properties of ES cells.
- 29 May 2003
- Published by Springer Nature in Nature
- Vol. 423 (6939) , 541-545
Open AccessRole of ERas in promoting tumour-like properties in mouse embryonic stem cells
Embryonic stem (ES) cells are pluripotent cells derived from early mammalian embryos1,2. Their immortality and rapid growth make them attractive sources for stem cell therapies3; however, they produce tumours (teratomas) when transplanted, which could preclude their therapeutic usage4. Why ES cells, which lack chromosomal abnormalities, possess tumour-like properties is largely unknown. Here we show that mouse ES cells specifically express a Ras-like gene, which we have named ERas. We show that human HRasp, which is a recognized pseudogene, does not contain reported base substitutions and instead encodes the human orthologue of ERas. This protein contains amino-acid residues identical to those present in active mutants of Ras5 and causes oncogenic transformation in NIH 3T3 cells. ERas interacts with phosphatidylinositol-3-OH kinase6 but not with Raf7,8. ERas-null ES cells maintain pluripotency but show significantly reduced growth and tumorigenicity, which are rescued by expression of ERas complementary DNA or by activated phosphatidylinositol-3-OH kinase. We conclude that the transforming oncogene ERas is important in the tumour-like growth properties of ES cells.